Stocks

Green Thumb Industries is reportedly the subject of a federal investigation over possible pay-to-play violations during the licensing process. The company called the allegations baseless and said it is unaware of any such investigation.

The SEC announced fraud charges on Monday against Irvine, California-based stock trader Andrew L. Fassari for allegedly using Twitter to spread lies about and drive up the stock price of a now-defunct cannabis company.

Verano Holdings in Chicago is facing a RICO lawsuit for allegedly having an employee illegally transport cannabis clippings from Illinois to Arkansas. The company has called the charges “totally false and absurd.”

Curaleaf Holdings is set to acquire EMMAC Life Sciences Ltd., Europe’s largest vertically integrated cannabis company, for approximately $286 million.

An influential Democrat from Kentucky is accused of unethical stock purchases after buying up multiple cannabis stocks prior to endorsing the MORE Act, which was passed by the House in December.

Cannabis company Parallel has entered into an acquisition agreement with Ceres Acquisition Corp that would see the combined company go public.

Chicago-based Verano Holdings Corp. is now trading on the Canadian Securities Exchange following its reverse takeover of Majesta Minerals Inc. on Wednesday.

WallStreetBets, the Reddit-based forum behind the “GameStonk” phenomenon that rocked the stock market last month, set its sights this week on the cannabis space.

GW Pharmaceuticals, creator of the first FDA-approved medication made from cannabis, is set to be purchased by Jazz Pharmaceuticals in a $7.2 billion cash-and-stock deal.

Cannabis grow tech company Agrify began trading on the Nasdaq last week; the company is not a plant-touching business but provides cultivation solutions for professional indoor cannabis growers.

Anticipating accelerated cannabis reforms around the country, Curaleaf Holdings yesterday announced an offering of 16.5 million subordinate voting shares at C$16.70 per share.

Multiple hemp and cannabis firms say they are planning initial public offerings under the assumption that Joe Biden will win the presidential election next month.

Medical cannabis companies licensed in the United Kingdom are now eligible for listing on the London Stock Exchange.

A new CBD product line by Martha Stewart and Canopy Growth launches this week after more than a year in development.

New York-based Columbia Care has agreed to acquire Project Cannabis, a California cannabis brand, in a $69 million stock and cash deal.

California cannabis company Vibe Bioscience is set to acquire Cathedral Asset Holding Corporation, a wholly-owned subsidiary of Ventura Cannabis and Wellness Corp.

The FDA has expanded the label of Epidiolex, the first CBD-based medication approved by the federal agency, to treat seizures resulting from tuberous sclerosis complex.

Hawthorne, an indoor cultivation and hydroponics brand subsidiary of Scotts Miracle-Gro, reported 72 percent growth for the third quarter, which ended June 27, 2020.

Curaleaf has successfully completed its acquisition of Grassroots to become the largest vertically-integrated cannabis operator in the country.

iAnthus Capital Holdings, Inc. has announced a recapitalization plan that would leave shareholders either 2.75 percent of the company or nothing.

During the nearly two years of federal legalization in Canada, no single cannabis brand has earned more than 41 percent recognition among consumers.

The SEC has ordered a halt to the High Times IPO after the company missed its annual report deadline in June; recent marketing material, however, suggests that fundraising efforts are still underway.

Collective Growth Corp., the new hemp investment and acquisition venture headed by veteran cannabis CEO Bruce Linton, raised $150 million in its recent IPO.

Cannabis companies are paying insurance rates that are up to seven times higher than other industries with many citing a rise in U.S. lawsuits against publicly traded cannabis firms.